REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 99 filers reported holding REPLIMUNE GROUP INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233,569 | -97.5% | 13,651 | -96.6% | 0.00% | -100.0% |
| Q2 2023 | $9,377,931 | +90220.1% | 403,873 | -31.3% | 0.01% | -16.7% |
| Q1 2023 | $10,383 | +38.6% | 587,961 | +113.4% | 0.01% | +50.0% |
| Q4 2022 | $7,493 | -99.7% | 275,496 | +99.5% | 0.00% | +300.0% |
| Q3 2022 | $2,385,000 | +33.8% | 138,113 | +35.5% | 0.00% | 0.0% |
| Q2 2022 | $1,782,000 | +692.0% | 101,966 | +668.8% | 0.00% | – |
| Q1 2022 | $225,000 | -92.0% | 13,263 | -87.2% | 0.00% | -100.0% |
| Q4 2021 | $2,814,000 | +7.4% | 103,826 | +17.4% | 0.00% | -50.0% |
| Q3 2021 | $2,621,000 | -42.9% | 88,432 | -26.1% | 0.00% | -33.3% |
| Q2 2021 | $4,594,000 | +57.1% | 119,584 | +24.8% | 0.00% | +50.0% |
| Q1 2021 | $2,924,000 | -64.3% | 95,822 | -55.4% | 0.00% | -66.7% |
| Q4 2020 | $8,189,000 | +3124.0% | 214,664 | +1843.4% | 0.01% | – |
| Q3 2020 | $254,000 | -57.2% | 11,046 | -81.5% | 0.00% | -100.0% |
| Q1 2020 | $594,000 | -56.2% | 59,602 | -36.9% | 0.00% | -50.0% |
| Q4 2019 | $1,355,000 | – | 94,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |